We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$421M
1-Year Est. Return
16.18%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$165M
AUM Growth
+$4.34M
(+2.7%)
Cap. Flow
+$1.88M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
23.21%
Holding
95
New
1
Increased
36
Reduced
23
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$667K |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$582K |
| 3 |
Apple
AAPL
|
+$308K |
| 4 |
Clorox
CLX
|
+$198K |
| 5 |
Abbott
ABT
|
+$185K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$517K |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$463K |
| 3 |
Waste Management
WM
|
+$227K |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$73.2K |
| 5 |
Xylem
XYL
|
+$71.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.35% |
| 2 | Technology | 12.09% |
| 3 | Healthcare | 11.32% |
| 4 | Financials | 10.96% |
| 5 | Consumer Staples | 10.5% |
Similar funds
SCV
RAG
TFP
AFA
CWM
MG
HWMG
AI
Boston Research & Management's Q2 2016 Portfolio in Review
As of Q2 2016, Boston Research & Management held 95 positions worth $165M, up 2.7% from $161M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q2 2016: portfolio turnover was 1.1%. Boston Research & Management opened 1 new position and made no exits, leaving the 95-position portfolio largely intact.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Boston Research & Management's largest Q2 2016 buy was Clorox: 1,530 shares worth $211K.
- Boston Research & Management added most to iShares Core MSCI Emerging Markets ETF in Q2 2016, an estimated $667K increase.
- Boston Research & Management's biggest Q2 2016 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $517K.
- Boston Research & Management's ten largest holdings make up 23% of its $165M portfolio in Q2 2016.
- Boston Research & Management opened 1 new position and closed 0 in Q2 2016.
- Boston Research & Management's portfolio value rose 2.7% quarter-over-quarter to $165M.
Based on Boston Research & Management's 13F filing for Q2 2016, filed 10 Aug 2016.